Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Encephalitis Treatment Market
Encephalitis Treatment Market Size
- Report ID: GMI5756
- Published Date: May 2023
- Report Format: PDF
Encephalitis Treatment Market Size
Encephalitis Treatment Market size was evaluated to be around USD 20.6 billion in 2022 and is anticipated to exhibit sustainable growth at a CAGR of around 4.7% during the forecast period. This is attributed primarily to factors such as the growing incidence of encephalitis, increasing awareness about disease treatments, and healthcare expenditure.
Encephalitis is a rare but life-threatening brain disease. Encephalitis is a brain inflammation that occurs due to an infection caused by viruses, bacteria, or immune system malfunction. Encephalitis causes various physical and neurological symptoms such as fever, headaches, stiff neck, muscle weakness and pain, behavioural changes, confusion, memory issues, seizures, sensitivity to light and loss of consciousness. Prompt diagnosis and treatment of encephalitis is crucial as it can affect the individual severely.
The symptoms of encephalitis can be mild to severe and needs to be treated urgently. The management of encephalitis is done using antiviral drugs, steroids, antibiotics, immunoglobulin therapies, plasmapheresis, and other medications like anticonvulsant, and antifungal medications.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Encephalitis Treatment Market Size in 2022: | USD 20.6 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 4.7% |
| 2032 Value Projection: | USD 32.6 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 160 |
| Tables, Charts & Figures: | 282 |
| Segments covered: | Disease type, Treatment, Route of administration, End-user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Encephalitis Treatment Market Scope
